Cover Image
Market Research Report

Autotransfusion Systems Market by Type (Autotransfusion Products & Accessories) and Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other Procedures) - Global Forecast to 2024

Published by MarketsandMarkets Product code 907161
Published Content info 116 Pages
Delivery time: 1-2 business days
Price
Back to Top
Autotransfusion Systems Market by Type (Autotransfusion Products & Accessories) and Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other Procedures) - Global Forecast to 2024
Published: August 15, 2019 Content info: 116 Pages
Description

"The autotransfusion systems market is projected to grow at a CAGR of 5.0%."

The autotransfusion systems market is projected to reach USD 505 million by 2024 from USD 395 million in 2019, at a CAGR of 5.0%. The growth of this market is driven by the increasing number of surgical procedures, rising number of transplant procedures, advantages of autotransfusion, and scarcity of donated blood/allogenic blood.

"The autotransfusion products segment is expected to witness the highest growth in the autotransfusion systems market during the forecast period."

On the basis of type, the autotransfusion systems market is segmented into autotransfusion products & autotransfusion accessories. The autotransfusion products segment is estimated to grow at the highest CAGR during the forecast period owing to a number of advantages, which is expected to boost its adoption in the coming years. These components prevent the transmission of transfusion-related blood-borne diseases in patients, and they also provide more compatible blood than in the case of autologous blood transfusions. These advantages are likely to increase the demand for autotransfusion products.

"The cardiac surgeries segment, by application, is expected to witness the highest growth during the forecast period."

On the basis of application, the autotransfusion systems market is segmented into Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other Procedures. The Cardiac Surgeries segment is estimated to grow at the highest rate during the forecast period due to the high prevalence of cardiac diseases and recommendations for autologous transfusion (by entities such as the WHO) during cardiac surgeries.

"Asia Pacific is expected to grow at the highest CAGR in the market, by region, during the forecast period."

Growth in this market segment is primarily due to the presence of a large target patient population in countries such as China and India, improving healthcare infrastructure, rising healthcare spending, increasing per capita income, and rising focus of key market players in strengthening their presence in several Asia Pacific countries.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (25%), Tier 2 (30%), and Tier 3 (45%)
  • By Designation: C-level (26%), Director-level (30%), and Others (44%)
  • By Region: North America (34%), Europe (26%), APAC (23%), and RoW (17%)

The major players operating in the global autotransfusion systems market are: Medtronic Plc (Ireland), Becton, Dickinson and Company (US), Zimmer Biomet Holdings, Inc (US), Teleflex Incorporated (US), LivaNova (UK), Fresenius (Germany), Atrium Medical Corporation (Sweden), Haemonetics Corporation (US), SARSTEDT (Germany), Braile Biomedica (Brazil), Redax (Italy), Beijing ZKSK Technology Co (China), and Gen World Medical Devices (India) are some of the leading players.

Research Coverage:

This report studies the autotransfusion systems market by type, application, and region. It also covers factors affecting market growth, analyzes various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends and forecasts the size of market segments with respect to key regions-North America, Europe, Asia Pacific, and the Rest of the World.

Reasons to Buy the Report:

From an insights perspective, this research report focuses on various levels of analysis-market ranking the analysis of the top players and their company profiles, which together comprise and discuss basic views on the competitive landscape; emerging segments of the autotransfusion systems market and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

Table of Contents
Product Code: MD 7292

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY SOURCES
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2 PRIMARY RESEARCH VALIDATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 AUTOTRANSFUSION SYSTEMS: MARKET OVERVIEW
  • 4.2 AUTOTRANSFUSION SYSTEMS MARKET SHARE, BY TYPE
  • 4.3 AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • 4.4 AUTOTRANSFUSION SYSTEMS MARKET, BY REGION

5 MARKET OVERVIEW

  • 5.1 MARKET DYNAMICS
    • 5.1.1 DRIVERS
      • 5.1.1.1 Increasing number of surgical procedures
      • 5.1.1.2 Rising number of transplant procedures
      • 5.1.1.3 Advantages of autotransfusion
      • 5.1.1.4 Scarcity of donated blood/allogenic blood
    • 5.1.2 RESTRAINTS
      • 5.1.2.1 High costs associated with autotransfusion systems
      • 5.1.2.2 Risks associated with autotransfusion
      • 5.1.2.3 Government initiatives to streamline the allogenic/donated blood supply
    • 5.1.3 OPPORTUNITIES
      • 5.1.3.1 Emerging economies offer high growth potential
    • 5.1.4 CHALLENGES
      • 5.1.4.1 Scarcity of resources such as well-trained perfusionists and surgical technicians in developing countries
    • 5.1.5 MARKET TRENDS
      • 5.1.5.1 Development of low-cost autotransfusion devices

6 AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 AUTOTRANSFUSION PRODUCTS
    • 6.2.1 AUTOTRANSFUSION PRODUCTS MARKET SPLIT, BY APPLICATION, 2017-2024 (USD MILLION)
    • 6.2.2 INTRAOPERATIVE AUTOTRANSFUSION SYSTEMS
      • 6.2.2.1 Advantages of intraoperative blood autotransfusion to drive the growth of this segment
      • 6.2.2.2 Intraoperative autotransfusion systems market split, by application, 2017-2024 (USD million)
    • 6.2.3 POSTOPERATIVE AUTOTRANSFUSION SYSTEMS
      • 6.2.3.1 Postoperative autotransfusion systems have wide usage in trauma procedures
      • 6.2.3.2 Postoperative autotransfusion systems market split, by application, 2017-2024 (USD million)
    • 6.2.4 DUAL-MODE AUTOTRANSFUSION SYSTEMS
      • 6.2.4.1 Dual-mode autotransfusion systems have major applications in treatment procedures for massive trauma and malignant surgeries
      • 6.2.4.2 Dual-mode autotransfusion systems market split, by application, 2017-2024 (USD million)
  • 6.3 AUTOTRANSFUSION ACCESSORIES
    • 6.3.1 AUTOTRANSFUSION ACCESSORIES MARKET SPLIT, BY APPLICATION, 2017-2024 (USD MILLION)

7 AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 CARDIAC SURGERIES
    • 7.2.1 CARDIAC SURGERIES FORM THE LARGEST APPLICATION SEGMENT IN THE AUTOTRANSFUSION SYSTEMS MARKET
  • 7.3 ORTHOPEDIC SURGERIES
    • 7.3.1 RISING NUMBER OF ORTHOPEDIC PROCEDURES WILL SUPPORT MARKET GROWTH
  • 7.4 ORGAN TRANSPLANTATION
    • 7.4.1 RISING DISEASE PREVALENCE AND NEED FOR ORGAN DONATIONS WILL DRIVE DEMAND FOR AUTOTRANSFUSION SYSTEMS
  • 7.5 TRAUMA PROCEDURES
    • 7.5.1 HIGH LEVELS OF BLOOD LOSS IN TRAUMA PROCEDURES WILL SUPPORT USE OF AUTOTRANSFUSION SYSTEMS
  • 7.6 OTHER PROCEDURES

8 AUTOTRANSFUSION SYSTEMS MARKET, BY REGION

  • 8.1 INTRODUCTION
  • 8.2 NORTH AMERICA
    • 8.2.1 US
      • 8.2.1.1 Rising number of transplant procedures in the US to drive market growth
    • 8.2.2 CANADA
      • 8.2.2.1 Rising concerns over the risks associated with homologous blood transfusion to support market growth in Canada
  • 8.3 EUROPE
    • 8.3.1 GERMANY
      • 8.3.1.1 Significant healthcare spending in the country to support market growth
    • 8.3.2 FRANCE
      • 8.3.2.1 Growing awareness and support for organ donation to propel the growth of the autotransfusion systems market in France
    • 8.3.3 UK
      • 8.3.3.1 Increasing number of transplantation procedures in the UK to drive market growth
    • 8.3.4 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 JAPAN
      • 8.4.1.1 Rising geriatric population and universal healthcare coverage-major factors driving market growth in Japan
    • 8.4.2 CHINA
      • 8.4.2.1 Scarcity of donated blood to drive the adoption of autologous blood transfusion in China
    • 8.4.3 INDIA
      • 8.4.3.1 Presence of a large patient population and growing access to healthcare driving market growth in India
    • 8.4.4 REST OF ASIA PACIFIC
  • 8.5 REST OF THE WORLD
    • 8.5.1 LATIN AMERICA
    • 8.5.2 MIDDLE EAST
    • 8.5.3 AFRICA

9 COMPETITIVE LANDSCAPE

  • 9.1 INTRODUCTION
  • 9.2 MARKET RANKING ANALYSIS
  • 9.3 COMPETITIVE SCENARIO
    • 9.3.1 ACQUISITIONS
    • 9.3.2 AGREEMENTS
  • 9.4 COMPETITIVE LEADERSHIP MAPPING
    • 9.4.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2017)
      • 9.4.1.1 Visionary leaders
      • 9.4.1.2 Innovators
      • 9.4.1.3 Dynamic players
      • 9.4.1.4 Emerging companies

10 COMPANY PROFILES

(Business overview, Products offered, Recent developments & MnM View)*

  • 10.1 ATRIUM MEDICAL CORPORATION (A PART OF GETINGE GROUP)
  • 10.2 BECTON, DICKINSON AND COMPANY
  • 10.3 BEIJING ZKSK TECHNOLOGY CO., LTD.
  • 10.4 BRAILE BIOMEDICA
  • 10.5 FRESENIUS MEDICAL CARE AG & CO. KGAA
  • 10.6 GEN WORLD MEDICAL DEVICES
  • 10.7 HAEMONETICS CORPORATION
  • 10.8 LIVANOVA PLC
  • 10.9 MEDTRONIC PLC
  • 10.10 REDAX
  • 10.11 SARSTEDT AG & CO. KG
  • 10.12 TELEFLEX INCORPORATED
  • 10.13 ZIMMER BIOMET HOLDINGS INC.

Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.

11 APPENDIX

  • 11.1 DISCUSSION GUIDE
  • 11.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.3 AVAILABLE CUSTOMIZATIONS
  • 11.4 RELATED REPORTS
  • 11.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 2: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 3: AUTOTRANSFUSION PRODUCTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 4: AUTOTRANSFUSION PRODUCTS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 5: INTRAOPERATIVE AUTOTRANSFUSION SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: INTRAOPERATIVE AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 7: POSTOPERATIVE AUTOTRANSFUSION SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: POSTOPERATIVE AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 9: DUAL-MODE AUTOTRANSFUSION SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 10: DUAL-MODE AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 11: AUTOTRANSFUSION ACCESSORIES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: AUTOTRANSFUSION ACCESSORIES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 13: AUTOTRANSFUSION SYSTEMS (ATS) MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 14: AUTOTRANSFUSION SYSTEMS MARKET FOR CARDIAC SURGERIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: AUTOTRANSFUSION SYSTEMS MARKET FOR ORTHOPEDIC SURGERIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: REQUIRED UNITS OF BLOOD AND BLOOD COMPONENTS, BY TYPE OF TRANSPLANT SURGERY
  • TABLE 17: AUTOTRANSFUSION SYSTEMS MARKET FOR ORGAN TRANSPLANTATION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: AUTOTRANSFUSION SYSTEMS MARKET FOR TRAUMA PROCEDURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: AUTOTRANSFUSION SYSTEMS MARKET FOR OTHER PROCEDURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: TOTAL NUMBER OF SOLID ORGAN TRANSPLANTATION PROCEDURES ACROSS KEY COUNTRIES (2016)
  • TABLE 21: AUTOTRANSFUSION SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: NORTH AMERICA: AUTOTRANSFUSION SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 23: NORTH AMERICA: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 24: NORTH AMERICA: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 25: NORTH AMERICA: AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 26: US: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 27: US: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 28: CANADA: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 29: CANADA: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 30: EUROPE: AUTOTRANSFUSION SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 31: EUROPE: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 32: EUROPE: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 33: EUROPE: AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 34: GERMANY: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 35: GERMANY: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 36: FRANCE: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 37: FRANCE: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 38: ORGAN TRANSPLANTATION PROCEDURES PERFORMED IN THE UK, 2013 VS. 2015
  • TABLE 39: UK: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 40: UK: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 41: ROE: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 42: ROE: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 43: APAC: AUTOTRANSFUSION SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 44: APAC: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 45: APAC: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 46: APAC: AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 47: JAPAN: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 48: JAPAN: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 49: CHINA: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 50: CHINA: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 51: INDIA: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 52: INDIA: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 53: SOLID-ORGAN TRANSPLANTATION PROCEDURES PERFORMED IN ROAPAC COUNTRIES, 2013 VS. 2016
  • TABLE 54: ROAPAC: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 55: ROAPAC: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 56: ROW: AUTOTRANSFUSION SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 57: ROW: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 58: ROW: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 59: ROW: AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 60: LATAM: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 61: LATAM: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 62: MIDDLE EAST: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 63: MIDDLE EAST: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 64: AFRICA: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 65: AFRICA: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4: PRODUCT-BASED MARKET SIZE ESTIMATION: AUTOTRANSFUSION SYSTEM MARKET
  • FIGURE 5: APPLICATION-BASED MARKET SIZE ESTIMATION: AUTOTRANSFUSION SYSTEMS MARKET
  • FIGURE 6: DATA TRIANGULATION
  • FIGURE 7: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: AUTOTRANSFUSION SYSTEMS MARKET, BY REGION, 2019-2024
  • FIGURE 10: RISING NUMBER OF TRANSPLANT PROCEDURES GLOBALLY IS A KEY DRIVER FOR MARKET GROWTH
  • FIGURE 11: AUTOTRANSFUSION PRODUCTS HELD THE LARGEST SHARE OF THE MARKET IN 2018
  • FIGURE 12: CARDIAC SURGERIES DOMINATED THE AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION
  • FIGURE 13: APAC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 14: AUTOTRANSFUSION SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS
  • FIGURE 15: NUMBER OF KIDNEY TRANSPLANT PROCEDURES, BY COUNTRY, 2015 VS. 2018
  • FIGURE 16: NORTH AMERICA: AUTOTRANSFUSION SYSTEMS MARKET SNAPSHOT
  • FIGURE 17: SOLID-ORGAN TRANSPLANTATION PROCEDURES PERFORMED IN THE US, 2013-2017
  • FIGURE 18: SOLID-ORGAN TRANSPLANTATION PROCEDURES PERFORMED IN CANADA, 2015 VS. 2016
  • FIGURE 19: ASIA PACIFIC: AUTOTRANSFUSION SYSTEMS MARKET SNAPSHOT
  • FIGURE 20: AUTOTRANSFUSION SYSTEMS MARKET RANKING, BY KEY PLAYER, 2018
  • FIGURE 21: AUTOTRANSFUSION SYSTEMS MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
  • FIGURE 22: GETINGE GROUP: COMPANY SNAPSHOT
  • FIGURE 23: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 24: FRESENIUS GROUP: COMPANY SNAPSHOT
  • FIGURE 25: HAEMONETICS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 26: LIVANOVA PLC: COMPANY SNAPSHOT
  • FIGURE 27: MEDTRONIC PLC: COMPANY SNAPSHOT
  • FIGURE 28: TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 29: ZIMMER BIOMET HOLDINGS: COMPANY SNAPSHOT
Back to Top